Skip to content

Public FDA record

Z-3187-2018: Freedom EV0-2 with any version of EVOware and EVOware Sample Tracking Add-On V1.0 or higher

Recall record Z-3187-2018 for Tecan US, Inc.. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-3187-2018
Company in FDA record
Tecan US, Inc.
FDA record creation date
Oct 11, 2018
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 16, 2026
Recall classification
Class II

Reason stated in the source

There is a software issue that can potentially impact sample identification and traceability under specific conditions when using EVOware Add On Software: Sample Tracking -Multi Instrument V1.0 or higher, Part Number 30019971.

Source facts

Action
On July 23, 2018, Tecan sent Field Corrective Action Letters to their consignees advising them of the problem. Field corrections will be made in the near future.
Initiated
2018-07-23
Root cause
Device Design
Terminated
2020-08-26
Distribution
Nationwide distribution to CA, MA, NC, OH, TX, and VA. Worldwide distribution to Australia, Canada, China, EU, and Japan.
Recall number
Z-3187-2018
Recall status
Terminated
CDRH record ID
166131
FDA record created
2018-10-11
Recall event number
80672

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗